Broadfin Capital Initiates Stake in Newly Public Recro Pharma Inc (REPH)

Broadfin Capital, managed by Kevin Kotler, has disclosed in a new filing with the U.S. Securities and Exchange Commission holding shares of Recro Pharma Inc (NASDAQ:REPH), a company that went public a couple of days ago. The passive stake held by Broadfin, contains 580,000 shares, equal to 8.1% of the outstanding stock.

Kevin Kotler

Recro is a clinical-stage pharmaceutical company that is engaged in development of non-opioid therapeutics for the treatment of pain. It began trading on NASDAQ on March 7, and just yesterday closed its initial public offering during which it sold 3.75 million shares, at a public offering price of $8.00 per share. The offering included 562,500 shares that have been sold as under-allotment options. The gross proceeds amounted to some $34.5 million.

Prior to the IPO the company conducted a reverse stock split, under a 1-for-2.5 ratio. According to the company’s S-1 filing with the SEC, the largest shareholder, prior to the IPO, was SCP Vitalife Partners II, L.P., which after the offering held almost 2.0 million common shares, equal to over 36% of the stock.

Kevin Kotler has been very active in the post-IPO companies sector, during the past couple of weeks. Since the beginning of the year, Broadfin reported new positions in four companies, two of which being recently public companies. Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), is one of these companies, in which Broadfin disclosed a 5.55% stake. Also, a couple of days ago, the fund reported a new stake in Pernix Therapeutics (NASDAQ:PTX), which amasses over 9% of the outstanding shares.

Broadfin has a $758.1 equity portfolio heavily concentrated in the healthcare industry. In its latest 13F, the fund revealed its largest holding in Depomed Inc (NASDAQ:DEPO), followed by Lannett Company, Inc. (NYSE:LCI), in which the fund disclosed holding over 4.7 million and 1.3 million shares, worth $50.2 million and $44.4 million respectively.

Disclosure: none

Recommended Reading:

Matthew Drapkin Is Appointed to the Board of Comverse Inc (CNSI)

Bill Ackman Exercises Warrants and Buys 4 Mln Platform Specialty Products Corporation (PAH) Shares

Billionaire Ken Griffin Ups Stake in Arch Coal Inc (ACI) to Over 5%

Dividend Stock Alert - Billionaire Robbins' Top Dividend Idea With 70% Upside Potential

Get Paid 3.5% Per Year While Waiting For The Stock Appreciate 70%

Larry Robbins' Glenview Capital Opportunity Fund returned 101.7% in 2013 and Robbins personally made $750 million. The same fund returned 25.3% in 2014. In this FREE REPORT we will share Robbins' top dividend idea that yields 3.5% and has been increasing its dividends for 39 consecutive years. Robbins thinks the stock has the potential to appreciate 70%.

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!